The Burden of Lyme Disease (BOLD) in a Pandemic - Insights From an Online Cross-sectional and Prospective Cohort Survey

Dr. Daniel Cameron & Associates

Status: Unknown

Conditions: COVID-19; COVID-19 Vaccine; Lyme Disease

Treatments: Other: Cross sectional survey

Study type: Observational

Funder types: Other

Identifiers

NCT05312619

20212917

Details and patient eligibility

About

A cross-sectional descriptive survey of the BOLD for individuals after having been ill with COVID-19 or have taken the COVID-19 vaccine will be compared with that of individuals who have neither been ill with COVID-19 nor taken the COVID-19 vaccine. Individuals who have both been ill and taken the COVID-19 vaccine will be compared to identify any additive risk factors.

Full description

Primary research question:

1. Will the BOLD be worse for individuals who have taken the COVID-19 vaccine?

Secondary research questions:

1. Will the BOLD be worse for individuals who have been ill with COVID-19?
2. What factors affect the BOLD in individuals a) after having been ill with COVID-19, and b) in those who have taken the COVID-19 vaccine? Do they differ?
3. If BOLD risk factors specific to either the COVID-19 vaccine or having been ill with COVID-19 are found, are they additive in people who have experienced both?
4. What is the prevalence of hesitancy in the Lyme disease community to the COVID-19 vaccine?
5. What is the severity of symptoms most likely to predict functional problems in individuals with Lyme disease who have been ill with COVID-19 or taken the COVID-19 vaccine?

Enrollment: 2,000 estimated patients

Sex: All

Ages: 12+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• ≥12 years old
• a self-report of having been diagnosed with Lyme disease.

Exclusion criteria

• There are no exclusion criteria.